General Conditions for the use of Galenicum Health, S.L.U. website
In accordance with the provisions of Act 34/2002 of 11 July on Information Society Services and Electronic Commerce, we inform this website is operated by Galenicum Health, S.L.U.
The use of this website constitutes acceptance of each of the conditions included in this legal advice and agrees to abide by Spanish law at all times expressly waiving any other jurisdiction. These conditions and regulations will force each time you access the Galenicum Health, S.L.U. website, therefore, it is important to read it carefully.
Warranties and Disclaimers
User acknowledges and voluntary and expressly accepts, that the use of the website www.galenicumaxium.com is made under his/her sole and exclusive responsibility at all times. Consequently, user is committed to not execute any action which can infringe the law or the conditions included in this legal advice such as accessing the website through mechanized systems, introducing programs, or other harmful elements which could damage, disable or overload the website.
Galenicum Health, S.L.U. reserves the right to modify at any time and without prior notice, the information, appearance and structure contained in this website, as well as the right of cancelling information or suspending the accessibility to the website.
Galenicum Health, S.L.U. does not guarantee the non-existence of interruptions or errors while making use of the website, and will not be responsible of any technical hitch or deficiencies during the Internet connection. Likewise, the owner of the website excludes all liability that might arise from interference, omissions, and computer viruses, caused by reasons beyond the owner of the website as well as damage caused by third parties through illicit interferences beyond the control of the owner of the website.
The company does not guarantee the non-existence of viruses or any other damaging elements that may cause alterations to the user’s computer systems (hardware and software) or to his/her electronic documents and files contained in the systems, therefore excludes all liability for damages to the user’s computer systems, electronic documents and files.
Hypertext links and Linked Sites
The company does not declare the existence of any relationship between Galenicum Health, S.L.U. and the owner of the website where the hyperlink is inserted. Likewise, the company reserves the right to cancel any hyperlink at any time.
According with this and with the provisions of the Act 34/2002 of 11 July on Information Society Services and Electronic Commerce, any third party hyperlink to this website should be done to the main or home page, and must obtain prior written authorization from Galenicum Health, S.L.U. Consequently, would not be allowed to modify, restrict or make any kind of opinion on this website, ensuring the compliance of the provisions of this legislation.
All the texts, audiovisual contents, source code, graphic design, logos, trademarks and other contents included in the website www.galenicumaxium.com, own to Galenicum Health, S.L.U. and are protected by legislation in Intellectual and Industrial Property rights.
Under no circumstances shall access and browsing this website or hiring and use of the services offered therein imply a total or partial transfer of intellectual and industrial property rights to the user. Therefore, corresponds the sole exercise of this rights to Galenicum Health, S.L.U., and it is expressly prohibited any transmission, reproduction, distribution, public communication or a total or partial modification without the prior authorization from the company.
Advice regarding using E-mail
Please note that currently the confidentiality of information on the Internet is not guaranteed without further measures (e.g. encoding) when using e-mail. The content which is sent with an e-mail that is not encoded should be no more confidential than the content of a post card. Messages with valuable content should be sent by post to protect them and avoid a third party gaining access to their content.
If e-mail-addresses are transmitted to Galenicum (e.g. for working with us), these will only be used for this purpose and not be given to third parties.
The information contained in this section is aimed at the healthcare professional of the Pharmaceutical Industry, therefore, specialized training is required for its correct interpretation.
The products mentioned may have a different authorized data sheet in each country.
If you click the "accept" button, you are expressing your willingness to access the information explicitly intended for healthcare professionals.
DEVELOPMENT OF THE FIRST GENERIC PHARMACEUTICAL SPECIALTY WITH DABIGATRAN. Decision EMC/2755/2017, dated November 20, (DOGC núm. 7508 of 30/11/2017) regarding the call for NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT (file number RD17-1-0006). This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIÓ.